M
Martin Möckel
Researcher at Charité
Publications - 325
Citations - 8964
Martin Möckel is an academic researcher from Charité. The author has contributed to research in topics: Myocardial infarction & Emergency department. The author has an hindex of 43, co-authored 286 publications receiving 7630 citations. Previous affiliations of Martin Möckel include Humboldt University of Berlin & University of Gothenburg.
Papers
More filters
Journal ArticleDOI
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea : results from the BACH (Biomarkers in Acute Heart Failure) trial
Alan S. Maisel,Christian Mueller,Richard M. Nowak,W. Frank Peacock,Judd W. Landsberg,Piotr Ponikowski,Martin Möckel,Christopher Hogan,Alan H.B. Wu,Mark Richards,Paul Clopton,Gerasimos Filippatos,Salvatore Di Somma,Inder S. Anand,Leong L. Ng,Lori B. Daniels,Sean-Xavier Neath,Robert H. Christenson,Mihael Potocki,James McCord,Garret Terracciano,Dimitrios Th. Kremastinos,Oliver Hartmann,Stephan von Haehling,Andreas Bergmann,Nils G. Morgenthaler,Stefan D. Anker +26 more
TL;DR: MR-proANP is as useful as BNP for AHF diagnosis in dyspneic patients and may provide additional clinical utility when BNP is difficult to interpret, and MR-proADM identifies patients with high 90-day mortality risk and adds prognostic value to BNP.
Journal ArticleDOI
Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction.
Till Keller,Tanja Zeller,Francisco Ojeda,Stergios Tzikas,Lars Lillpopp,Christoph Sinning,Philipp S. Wild,Sabine Genth-Zotz,Ascan Warnholtz,Evangelos Giannitsis,Martin Möckel,Christoph Bickel,Dirk Peetz,Karl J. Lackner,Stephan Baldus,Thomas Münzel,Stefan Blankenberg +16 more
TL;DR: Among patients with suspected acute coronary syndrome, the introduction of highly sensitive troponin assays into clinical practice has substantially improved the evaluation of patients with chest pain and a serial change in hsTNI or cTnI levels from admission to 3 hours after admission may facilitate an early diagnosis of AMI.
Journal ArticleDOI
Future Biomarkers for Detection of Ischemia and Risk Stratification in Acute Coronary Syndrome
Fred S. Apple,Alan H.B. Wu,Johannes Mair,Jan Ravkilde,Mauro Panteghini,Jillian R. Tate,Franca Pagani,Robert H. Christenson,Martin Möckel,Oliver Danne,Allan S. Jaffe +10 more
TL;DR: Several biomarkers have demonstrated promise and need to be more thoroughly evaluated for commercial development for implementation into routine clinical and laboratory practice and interventional trials demonstrating that monitoring single or multiple biomarkers improves outcomes.
Journal ArticleDOI
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
Gregg W. Stone,Alexandra J. Lansky,Stuart J. Pocock,Bernard J. Gersh,George Dangas,S. Chiu Wong,Bernhard Witzenbichler,Giulio Guagliumi,Jan Z. Peruga,Bruce R. Brodie,Dariusz Dudek,Martin Möckel,Andrzej Ochała,Alison Kellock,Helen Parise,Roxana Mehran +15 more
TL;DR: In patients with ST-segment elevation myocardial infarction who were undergoing primary PCI, implantation of paclitaxel-eluting stents, as compared with bare-metal stent, significantly reduced angiographic evidence of restenosis and recurrent ischemia necessitating repeat revascularization procedures.
Journal ArticleDOI
IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays
Fred S. Apple,Allan S. Jaffe,Paul O. Collinson,Martin Möckel,Jordi Ordóñez-Llanos,Bertil Lindahl,Judd E. Hollander,Mario Plebani,Martin Than,Michael H.M. Chan +9 more
TL;DR: The initial undertaking of the TF-CB was to address two key issues pertaining to implementing high-sensitivity cardiac troponin assays in clinical practice: the 99th percentile upper reference limit (URL) and calculating serial change values in accord with the Universal Definition of AMI.